TP53 and endometrial cancer: In type-I endometrial cancer, the p53-positive rate was 10–44%, whereas a high rate of p53 expression was observed in 30–86% of type-II endometrial cancer [59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75] (Table 1).